v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited)
€ in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2025
EUR (€)
€ / shares
shares
Mar. 31, 2024
EUR (€)
€ / shares
shares
Revenue € 26 € 0
Cost of sales 20 0
Gross margin 6 0
Operating Expenses and Costs    
Selling and distribution expenses 240 53
General and administrative expenses 1,135 1,134
Research and development 440 221
Gain on deconsolidation/reconsolidation 0 (62,734)
Other Operating (income)/loss (3) 13
Total Operating Expenses and Costs 1,812 (61,313)
(Loss)/Income from Operations (1,806) 61,313
Other Income (Expenses)    
Income from changes in fair value of convertible note payable carried at fair value 10,331 21,062
Gain (Loss) on foreign currency transactions 312 (1,498)
Total Other Income 10,643 19,564
Net Income € 8,837 € 80,877
Net income (loss) per share to common shareholders:    
Basic (in EUR per Share) | € / shares € 6.09 € 55.8
Diluted (in EUR per Share) | € / shares € 0.86 € 5.49
Weighted average number of common shares:    
Basic (in shares) | shares 1,449,918 1,449,485
Diluted (in shares) | shares 10,302,853 14,727,612